Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, May 17 '25)

Image
By G.M.

 


    Am J Respir Crit Care Med

  1. EDDY RL, Sin DD
    Loss of Lung Function Led to Loss of Life During the COVID-19 Pandemic.
    Am J Respir Crit Care Med. 2025.
    PubMed        


    Ann Intern Med

  2. JACOBS JW, Booth GS, Lewis-Newby M, Saifee NH, et al
    Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
    Ann Intern Med. 2025 May 13. doi: 10.7326/ANNALS-25-00815.
    PubMed         Abstract available


    BMJ

  3. WISE J
    Covid-19: Attitudes shifted after politicians broke rules, report says.
    BMJ. 2025;389:r960.
    PubMed        


    Br J Anaesth

  4. COPLEY S, Carty S, Brown M, Mishra S, et al
    Bridging the GAP: a critical analysis of pain management services in the United Kingdom.
    Br J Anaesth. 2025;134:1597-1602.
    PubMed         Abstract available


    Clin Infect Dis

  5. HAWKINS KL, Dandachi D, Verzani Z, Brannock MD, et al
    HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study.
    Clin Infect Dis. 2025 May 12:ciaf242. doi: 10.1093.
    PubMed         Abstract available

  6. KONOPNICKI D, Gilles C, Manigart Y, Barlow P, et al
    Immunogenicity and safety of two versus three doses of 9-valent vaccine against Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
    Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093.
    PubMed         Abstract available

  7. VALENCIA D, Edwards L, Horter L, Turner H, et al
    "I Didn't Know Him Before the Pandemic... Now He's on My Speed Dial": Strengthening Collaboration Between Infectious Diseases Physicians and State and Local Public Health for Future Public Health Emergencies.
    Clin Infect Dis. 2025 May 13:ciaf179. doi: 10.1093.
    PubMed         Abstract available

  8. AMARIN JZ, Toepfer AP, Spieker AJ, Hayek H, et al
    Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020.
    Clin Infect Dis. 2025 May 9:ciaf194. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  9. MACCANNELL D, MacInnis B, Santibanez S, Honein MA, et al
    A Decade of Partnerships and Progress in Pathogen Genomics in Public Health Practice.
    Emerg Infect Dis. 2025;31:1-2.
    PubMed        

  10. MOORE J, Sanon R, Khudyakov Y, Barnes N, et al
    Strategies and Opportunities to Improve Community Health through Advanced Molecular Detection and Genomic Surveillance of Infectious Diseases.
    Emerg Infect Dis. 2025;31:9-13.
    PubMed         Abstract available

  11. FLOREK KR, Young EL, Incekara K, Libuit KG, et al
    Advantages of Software Containerization in Public Health Infectious Disease Genomic Surveillance.
    Emerg Infect Dis. 2025;31:18-21.
    PubMed         Abstract available

  12. PORTER WT, Engelthaler DM, Hepp CM
    Genomic Epidemiology for Estimating Pathogen Burden in a Population.
    Emerg Infect Dis. 2025;31:22-24.
    PubMed         Abstract available

  13. JULES E, Decker C, Bixler BJ, Ahmed A, et al
    Respiratory Virus Detection and Sequencing from SARS-CoV-2-Negative Rapid Antigen Tests.
    Emerg Infect Dis. 2025;31:39-44.
    PubMed         Abstract available

  14. FRIEDMAN CR, Morfino RC, Ernst ET
    Leveraging a Strategic Public-Private Partnership to Launch an Airport-Based Pathogen Monitoring Program to Detect Emerging Health Threats.
    Emerg Infect Dis. 2025;31:35-38.
    PubMed         Abstract available

  15. EMMEN IE, Vuyk WC, Lail AJ, Wolf S, et al
    SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA.
    Emerg Infect Dis. 2025;31:61-69.
    PubMed         Abstract available

  16. FEISTEL DJ, Welsh R, Mercante J, Mark-Carew M, et al
    Detection and Tracking of SARS-CoV-2 Lineages through National Wastewater Surveillance System Pathogen Genomics.
    Emerg Infect Dis. 2025;31:57-60.
    PubMed         Abstract available

  17. PHAM K, Chaguza C, Lopes R, Cohen T, et al
    Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States.
    Emerg Infect Dis. 2025;31:45-56.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  18. BROWN MARUSIAK A, Sickbert-Bennett E, Babcock H, Westreich D, et al
    Characterizing presenteeism among healthcare personnel at an academic medical center across eras of the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2025 May 16:1-9. doi: 10.1017/ice.2025.
    PubMed         Abstract available

  19. STERN RA, Bashaw K, Talbot TR
    Isolating the burden of transmission-based precautions for COVID-19: walk-in clinic-based healthcare personnel perspectives.
    Infect Control Hosp Epidemiol. 2025 May 16:1-2. doi: 10.1017/ice.2025.
    PubMed        


    Int J Infect Dis

  20. INZAULE S, Silva R, Thwin SS, Waasila J, et al
    In-hospital Mortality Among Children and Adults Hospitalized with COVID-19 in Africa Across Pre-Delta, Delta, and Omicron SARS-CoV-2 Waves.
    Int J Infect Dis. 2025 May 7:107924. doi: 10.1016/j.ijid.2025.107924.
    PubMed         Abstract available


    J Infect

  21. GAO Y, Zhang J, Liu M, Bu Q, et al
    Superior antiviral efficacy of combined 3CL protease and RdRp inhibition compared to 3CL protease inhibitor monotherapy in hospitalized COVID-19 patients.
    J Infect. 2025;90:106502.
    PubMed        

  22. HOOG M, Westrhenen ESH, Winkel AM, Jong MD, et al
    Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohorts.
    J Infect. 2025 May 9:106501. doi: 10.1016/j.jinf.2025.106501.
    PubMed         Abstract available

  23. PETER RS, Sedelmaier L, Nieters A, Brockmann SO, et al
    Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study.
    J Infect. 2025;90:106500.
    PubMed         Abstract available


    J Med Virol

  24. WU Z, Fan S, Xu H, Feng F, et al
    Identifying Neurological Autoantibodies in COVID-19: mGluR2 as a Marker of Immune Dysregulation During the Omicron Outbreak in China.
    J Med Virol. 2025;97:e70381.
    PubMed         Abstract available

  25. HABEEBUR-RAHMAN SP, Khan FAA, Mohd-Azlan J, Gumal M, et al
    Comparative Analysis of Quan and Watanabe Pan-Coronavirus Assays for Bat Coronavirus Diversity in Sarawak, East Malaysia.
    J Med Virol. 2025;97:e70389.
    PubMed         Abstract available


    J Virol

  26. LV L, Luo H, Yi J, Zhang K, et al
    IFITM proteins are key entry factors for porcine epidemic diarrhea coronavirus.
    J Virol. 2025 May 12:e0202824. doi: 10.1128/jvi.02028.
    PubMed         Abstract available

  27. FRIEDLANDER AM
    Early short-course treatment fails to prevent disease or relapse upon discontinuance of treatment in infections in addition to COVID-19.
    J Virol. 2025 May 12:e0038125. doi: 10.1128/jvi.00381.
    PubMed        

  28. KONDO T, Suzuki R, Yajima H, Kawahara S, et al
    Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.
    J Virol. 2025 May 12:e0054325. doi: 10.1128/jvi.00543.
    PubMed         Abstract available

  29. FURUSAWA Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y, et al
    The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
    J Virol. 2025 May 13:e0065625. doi: 10.1128/jvi.00656.
    PubMed         Abstract available

  30. BROADBENT A
    A veterinary virapalooza: a summary of the 2024 American Society for Virology (ASV) Veterinary/Zoonotic Virology Satellite Symposium and online H5N1 panel discussion.
    J Virol. 2025 May 13:e0049925. doi: 10.1128/jvi.00499.
    PubMed         Abstract available


    Lancet Infect Dis

  31. SAADATIAN-ELAHI M, Rabilloud M, Mohlmann TWR, Langlois-Jacques C, et al
    Effectiveness of integrated vector management on the incidence of dengue in urban Malaysia: a cluster-randomised controlled trial.
    Lancet Infect Dis. 2025 May 12:S1473-3099(25)00086.
    PubMed         Abstract available


    Science

  32. CORNWALL W
    With Trump's cuts escalating, 'fear factor' silences researchers.
    Science. 2025;388:684-685.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »